José Cabeza Barrera-rekin lankidetzan egindako argitalpenak (6)

2021

  1. The relevance of monoclonal antibodies in the treatment of COVID-19

    Vaccines, Vol. 9, Núm. 6

2020

  1. Intact charge variant analysis of ziv-aflibercept by cationic exchange liquid chromatography as a proof of concept: Comparison between volatile and non-volatile salts in the mobile phase

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 185

2019

  1. Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA)

    BioDrugs, Vol. 33, Núm. 2, pp. 193-205

2018

  1. Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study

    International Journal of Biological Macromolecules, Vol. 116, pp. 993-1003

2016

  1. Study and ICH validation of a reverse-phase liquid chromatographic method for the quantification of the intact monoclonal antibody cetuximab

    Journal of Pharmaceutical Analysis, Vol. 6, Núm. 2, pp. 117-124

2013

  1. Quantification of an intact monoclonal antibody, rituximab, by (RP)HPLC/DAD in compliance with ICH guidelines

    Analytical and Bioanalytical Chemistry, Vol. 405, Núm. 29, pp. 9351-9363